Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281957788> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4281957788 endingPage "56" @default.
- W4281957788 startingPage "52" @default.
- W4281957788 abstract "Propranolol is the first-line agent for the treatment of infantile haemangioma (IH). Due to its non-selective beta blockade respiratory adverse events are commonplace. Atenolol is a selective beta-1 antagonist and is a second line for patients with a significant respiratory history or those intolerant of propranolol. Previous studies suggest that the two treatments are equally efficacious; however; the narrow side effect profile and once-daily administration of atenolol makes it an attractive alternative. The aim of this study was to compare the cost-effectiveness of atenolol and propranolol in the treatment of IH. Over a two-year period, five patients with nine IH received the first-line treatment with atenolol. Nine individual lesions from six propranolol patients were matched to these lesions, according to patient demographics and IH characteristics. Treatment response was determined by two independent clinician using both the Visual Analogue Score (VAS) and Haemangioma Activity Score (HAS). A cost-analysis of those treated with atenolol was undertaken and compared to the equivalent costing for standard and maximum dose propranolol. Treatment efficacy of atenolol was comparable to propranolol with mean change in VAS and HAS scores of -7.0 (vs -7.2) and 6.1 (vs 5.7), respectively. The cost analysis revealed atenolol was over 20 times less expensive than standard dose propranolol. In conclusion, the findings of this study suggest that atenolol is significantly less expensive and at least as effective as propranolol. These findings highlight the need for a multicentre randomised controlled trial to further investigate the cost-effectiveness of these two agents in the treatment of IH." @default.
- W4281957788 created "2022-06-13" @default.
- W4281957788 creator A5000113208 @default.
- W4281957788 creator A5024965865 @default.
- W4281957788 creator A5028896379 @default.
- W4281957788 creator A5042122245 @default.
- W4281957788 date "2022-09-01" @default.
- W4281957788 modified "2023-09-27" @default.
- W4281957788 title "Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study" @default.
- W4281957788 cites W1763526656 @default.
- W4281957788 cites W2033862870 @default.
- W4281957788 cites W2100584705 @default.
- W4281957788 cites W2125087480 @default.
- W4281957788 cites W2139447377 @default.
- W4281957788 cites W2155414885 @default.
- W4281957788 cites W2335898344 @default.
- W4281957788 cites W2415136777 @default.
- W4281957788 cites W2582743380 @default.
- W4281957788 cites W2618650691 @default.
- W4281957788 cites W3034067807 @default.
- W4281957788 cites W4236322841 @default.
- W4281957788 doi "https://doi.org/10.1016/j.jpra.2022.05.010" @default.
- W4281957788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35784377" @default.
- W4281957788 hasPublicationYear "2022" @default.
- W4281957788 type Work @default.
- W4281957788 citedByCount "1" @default.
- W4281957788 countsByYear W42819577882022 @default.
- W4281957788 crossrefType "journal-article" @default.
- W4281957788 hasAuthorship W4281957788A5000113208 @default.
- W4281957788 hasAuthorship W4281957788A5024965865 @default.
- W4281957788 hasAuthorship W4281957788A5028896379 @default.
- W4281957788 hasAuthorship W4281957788A5042122245 @default.
- W4281957788 hasBestOaLocation W42819577881 @default.
- W4281957788 hasConcept C126322002 @default.
- W4281957788 hasConcept C197934379 @default.
- W4281957788 hasConcept C2776525901 @default.
- W4281957788 hasConcept C2778151854 @default.
- W4281957788 hasConcept C42219234 @default.
- W4281957788 hasConcept C71924100 @default.
- W4281957788 hasConcept C84393581 @default.
- W4281957788 hasConceptScore W4281957788C126322002 @default.
- W4281957788 hasConceptScore W4281957788C197934379 @default.
- W4281957788 hasConceptScore W4281957788C2776525901 @default.
- W4281957788 hasConceptScore W4281957788C2778151854 @default.
- W4281957788 hasConceptScore W4281957788C42219234 @default.
- W4281957788 hasConceptScore W4281957788C71924100 @default.
- W4281957788 hasConceptScore W4281957788C84393581 @default.
- W4281957788 hasLocation W42819577881 @default.
- W4281957788 hasLocation W42819577882 @default.
- W4281957788 hasLocation W42819577883 @default.
- W4281957788 hasLocation W42819577884 @default.
- W4281957788 hasOpenAccess W4281957788 @default.
- W4281957788 hasPrimaryLocation W42819577881 @default.
- W4281957788 hasRelatedWork W144674851 @default.
- W4281957788 hasRelatedWork W1967092599 @default.
- W4281957788 hasRelatedWork W1980328625 @default.
- W4281957788 hasRelatedWork W2126060223 @default.
- W4281957788 hasRelatedWork W2150176629 @default.
- W4281957788 hasRelatedWork W2150460142 @default.
- W4281957788 hasRelatedWork W2618650691 @default.
- W4281957788 hasRelatedWork W2903448447 @default.
- W4281957788 hasRelatedWork W3034067807 @default.
- W4281957788 hasRelatedWork W4379508947 @default.
- W4281957788 hasVolume "33" @default.
- W4281957788 isParatext "false" @default.
- W4281957788 isRetracted "false" @default.
- W4281957788 workType "article" @default.